Clinical Trial Update: Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating chemotherapy plus HLA-mismatched GPBMC infusion as a bridge to allogeneic hematopoietic stem cell transplantation in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Chemotherapy (chemotherapy)
• HLA-mismatched GPBMC infusion (Graft-derived peripheral blood mononuclear cell infusion)

Snippet

Sponsor: Beijing 302 Hospital | Conditions: Relapsed Leukemia, Refractory Leukemia | Phase 1 | Status: RECRUITING